101 Views | 67 Downloads
Grace Y. Gombolay, Email: ggombol@emory.edu
The authors would like to thank research coordinators including Marco Benoit, Felicia Glover, Austin Lu, Lisa Macoy, Amber Samuel, Ashley Tippett, and Kathy Stephens, along with Children's Healthcare of Atlanta Research Laboratory along with the Emory Children's Clinical and Translational Discovery Core and patients and their families.
B.N., S.A.L, B.S., V.P., L.H., S.B., B.P., K.W., and L.W. have no disclosures. E.J.A. has received personal fees from AbbVie, Pfizer, and Sanofi Pasteur for consulting, and his institution receives funds to conduct clinical research unrelated to this manuscript from MedImmune, Regeneron, PaxVax, Pfizer, GSK, Merck, Novavax, Sanofi-Pasteur, Janssen, and Micron. He also serves on a safety monitoring board for Sanofi-Pasteur and Kentucky BioProcessing, Inc. C.A.R.’s institution has received funds to conduct clinical research unrelated to this manuscript from BioFire Inc, GSK, MedImmune, Micron, Janssen, Merck, Moderna, Novavax, PaxVax, Pfizer, Regeneron, Sanofi-Pasteur. She is co-inventor of patented RSV vaccine technology unrelated to this manuscript, which has been licensed to Meissa Vaccines, Inc. G.Y.G. receives salary support from the Centers for Disease Control and Prevention for surveillance for acute flaccid myelitis.
This work was funded by institutional funding from Emory University and Children's Center for Infections and Vaccines.
This study was supported in part by the Emory Multiplexed Immunoassay Core (EMIC), which is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support was provided by the National Center for Georgia Clinical & Translational Science Alliance of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.
© 2021 Elsevier B.V. All rights reserved.